BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38844254)

  • 1. Provider Specialization in Inflammatory Bowel Diseases: Quality of Care and Outcomes.
    Lewis JD; Brensinger CM; Parlett LE; Hurtado-Lorenzo A; Kappelman MD
    Clin Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38844254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narcotic use for inflammatory bowel disease and risk factors during hospitalization.
    Long MD; Barnes EL; Herfarth HH; Drossman DA
    Inflamm Bowel Dis; 2012 May; 18(5):869-76. PubMed ID: 21739533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
    Hashash JG; Elkins J; Lewis JD; Binion DG
    Gastroenterology; 2024 Mar; 166(3):521-532. PubMed ID: 38276922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
    Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
    J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in care of patients with elderly-onset inflammatory bowel disease in Ontario, Canada: A population-based cohort study.
    Kuenzig ME; Stukel TA; Kaplan GG; Murthy SK; Nguyen GC; Talarico R; Benchimol EI
    J Can Assoc Gastroenterol; 2021 Apr; 4(2):e16-e30. PubMed ID: 33855268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
    Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
    Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.
    Nguyen GC; Targownik LE; Singh H; Benchimol EI; Bitton A; Murthy SK; Bernstein CN; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S68-S72. PubMed ID: 31294386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery in the age of biologics.
    Wong DJ; Roth EM; Feuerstein JD; Poylin VY
    Gastroenterol Rep (Oxf); 2019 Apr; 7(2):77-90. PubMed ID: 30976420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in Provider Connectedness Associates With Outcomes of Inflammatory Bowel Diseases in an Analysis of Data From a National Health System.
    Cohen-Mekelburg S; Yu X; Costa D; Hofer TP; Krein S; Hollingsworth J; Wiitala W; Saini S; Zhu J; Waljee A
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2302-2311.e1. PubMed ID: 32798705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Sheehan JL; Jacob J; Berinstein EM; Greene-Higgs L; Steiner CA; Berry SK; Shannon C; Cohen-Mekelburg SA; Higgins PDR; Berinstein JA
    Inflamm Bowel Dis; 2022 Dec; 28(12):1904-1914. PubMed ID: 35230420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
    Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in the Care of Children with Inflammatory Bowel Disease Within and Across Canadian Provinces: A Multi-Province Population-Based Cohort Study.
    Kuenzig ME; Stukel TA; Carroll MW; Kaplan GG; Otley AR; Singh H; Bitton A; Fung SG; Spruin S; Coward S; Cui Y; Nugent Z; Griffiths AM; Mack DR; Jacobson K; Nguyen GC; Targownik LE; El-Matary W; Bernstein CN; Dummer TJB; Jones JL; Lix LM; Murthy SK; Peña-Sánchez JN; Nasiri S; Benchimol EI;
    Clin Epidemiol; 2024; 16():91-108. PubMed ID: 38374886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of real-world data to assess the effectiveness of ustekinumab in treating IBD patients: a retrospective linked database study in northwest London.
    Kamperidis N; Shah M; Young S; Galimov E; Sweeney S; Arebi N
    Expert Opin Biol Ther; 2023; 23(12):1317-1329. PubMed ID: 38009339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shifting Health Care Use from Hospitalisations and Surgeries to Outpatient Visits in Children with Inflammatory Bowel Disease: A Population-based Cohort Study from Ontario, Canada.
    Dheri AK; Kuenzig ME; Mack DR; Murthy SK; Kaplan GG; Donelle J; Smith G; Benchimol EI
    J Crohns Colitis; 2021 Dec; 15(12):1991-2000. PubMed ID: 34019625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy: A Multicenter Experience from Romania.
    Pavel C; Diculescu M; Constantinescu G; Plotogea OM; Sandru V; Meianu C; Dina I; Pop I; Butuc A; Mihaila M; Stan-Ilie M
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.